Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
3
×
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
crispr
deals
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
What
bio
3
×
medicines
3
×
covid
ipo
roundup
years
acquisitions
activity
announced
approvals
biogen
ceo
clamped
collabs
create
crispr
daniel
deal
delays
developing
diagnostic
diseases
economic
editing
fast
fda
fix
gene
gilead
gilead’s
heats
help
high
human
including
introduce
isn’t
launches
lot
month
Language
unset
Current search:
bio
×
startups
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M